Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England, Leeds |
| Main Category: | Services |
| Procurement Method: | Other - |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | £140,671 |
| Release Date: | 3 September 2025 |
| Application Deadline: | 5 May 2025 |
| Contract Start Date: | 11 May 2025 (Estimated) |
| Contract End Date: | 31 March 2026 (Estimated) |
| Contract Duration: |
View Original Notice
Access the full notice on the official portal
The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.
Published contracts in the last 12 months
34
total contracts
£2024.5m
total value
£63,265,490
average contract size
Typical categories
Pipeline status
Not addedContract imported automatically · AI writes the response
Application Deadline
5 May 2025
Closed
Estimated Value
£140,671
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| 11 months |
| Procurement ID (OCID): | ocds-b5fd17-4ae36907-e480-42d5-845e-5aaee77248d4 |
| Notice Reference: | d966c341-a622-49a0-b6f4-29dbbc3b93bf-862055 |